Macrophage-Derived CuET Vesicles Synergistically Enhance Paclitaxel Efficacy by Inhibiting Tumor Growth and Boosting Immunity in Breast Cancer
MEVs@CuET significantly enhances paclitaxel's efficacy by inducing cuproptosis and modulating antitumor immunity, offering a promising strategy to overcome resistance in breast cancer treatment.
Authors
- Lina Zhou (ORCID: https://orcid.org/0000-0003-1973-5667)
- Yinhua Lv (ORCID: https://orcid.org/0000-0001-6173-2625)
- Wen Zhang (ORCID: https://orcid.org/0000-0001-5166-0736)
- Xia Guo (ORCID: https://orcid.org/0000-0003-4889-2696)
- Jinlan Jiao
- Jiahui Ye
- Anya Buerliesi
- Wenqian Wei
- Yun Zhu
- Weihong Ge
Institutions
- Nanjing Drum Tower Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/ijn.s570540
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00